Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09

Background and purpose: Patient-level benefits of proton beam therapy (PBT) relative to photon therapy for prostate cancer (PC) continue to be the focus of debate. Although trials comparing the two modalities are underway, most are being conducted using “conventional” PBT (passive scattering/uniform...

Full description

Bibliographic Details
Main Authors: Mark V. Mishra, Rahul Khairnar, Søren M. Bentzen, Gary Larson, Henry Tsai, Christopher Sinesi, Carlos Vargas, George Laramore, Carl Rossi, Lane Rosen, Mingyao Zhu, William Hartsell
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:Clinical and Translational Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630819300941
id doaj-031e37d1c1554c70a00bfe099aa11992
record_format Article
spelling doaj-031e37d1c1554c70a00bfe099aa119922021-06-02T11:48:25ZengElsevierClinical and Translational Radiation Oncology2405-63082019-11-01198086Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09Mark V. Mishra0Rahul Khairnar1Søren M. Bentzen2Gary Larson3Henry Tsai4Christopher Sinesi5Carlos Vargas6George Laramore7Carl Rossi8Lane Rosen9Mingyao Zhu10William Hartsell11Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States; Corresponding author at: Department of Radiation Oncology, University of Maryland School of Medicine, 22 S. Greene Street, GGK 0101, Baltimore, MD 21201, United States.Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD, United StatesDepartment of Epidemiology & Public Health, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United StatesProCure Proton Therapy Center, Oklahoma City, OK, United StatesProCure Proton Therapy Center, Somerset, NJ, United StatesHampton University Proton Therapy Institute, Hampton, VA, United StatesDepartment of Radiation Oncology, Mayo Clinic Arizona, Phoenix, AZ, United StatesUniversity of Washington, Department of Radiation Oncology, Seattle, WA, United StatesCalifornia Protons Cancer Therapy Center, San Diego, CA, United StatesWillis-Knighton Proton Therapy Center, Shreveport, LA, United StatesDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United StatesNorthwestern Medicine Chicago Proton Center, Warrenville, IL, United StatesBackground and purpose: Patient-level benefits of proton beam therapy (PBT) relative to photon therapy for prostate cancer (PC) continue to be the focus of debate. Although trials comparing the two modalities are underway, most are being conducted using “conventional” PBT (passive scattering/uniform scanning [PS/US]) rather than pencil beam scanning (PBS). The dosimetric benefits of PBS are well-known, but comparative data are limited. This analysis compares PBS toxicity rates with those of PS/US in a prospective multicenter registry. Methods: We evaluated acute/late gastrointestinal (GI) and genitourinary (GU) toxicity rates for men with low-to-intermediate risk PC enrolled in PCG 001-09. Acute toxicities with the two techniques were compared using χ2 tests, and the cumulative incidence methods for late toxicity. Multivariable analyses (MVAs) for acute toxicity were performed using logistic regression, and cox proportional hazards models for late toxicity. Results: Patients were treated using PS/US (n = 1105) or PBS (n = 238). Acute grade ≥2 GI toxicity in PBS did not significantly differ from that with PS/US (2.9% and 2.1%, respectively; P = 0.47). Acute grade ≥2 GU toxicity was significantly higher with PBS (21.9% and 15.1%; P < 0.01). In MVA, PBS was significantly associated with increased acute grade ≥2 GU toxicity (RR = 1.57, p < 0.001). Late grade ≥2 GI and GU toxicities did not differ significantly between groups. Conclusions: This is the first multi-institutional comparative effectiveness evaluation of PBT techniques in PC. Differences in acute GU toxicity warrant further evaluation, and highlight the urgent need for prospective data using PBT. Keywords: Prostate cancer, Proton therapy, Pencil beam scanning, Passive scattering, uniform scanning, Comparative effectiveness, Toxicityhttp://www.sciencedirect.com/science/article/pii/S2405630819300941
collection DOAJ
language English
format Article
sources DOAJ
author Mark V. Mishra
Rahul Khairnar
Søren M. Bentzen
Gary Larson
Henry Tsai
Christopher Sinesi
Carlos Vargas
George Laramore
Carl Rossi
Lane Rosen
Mingyao Zhu
William Hartsell
spellingShingle Mark V. Mishra
Rahul Khairnar
Søren M. Bentzen
Gary Larson
Henry Tsai
Christopher Sinesi
Carlos Vargas
George Laramore
Carl Rossi
Lane Rosen
Mingyao Zhu
William Hartsell
Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09
Clinical and Translational Radiation Oncology
author_facet Mark V. Mishra
Rahul Khairnar
Søren M. Bentzen
Gary Larson
Henry Tsai
Christopher Sinesi
Carlos Vargas
George Laramore
Carl Rossi
Lane Rosen
Mingyao Zhu
William Hartsell
author_sort Mark V. Mishra
title Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09
title_short Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09
title_full Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09
title_fullStr Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09
title_full_unstemmed Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09
title_sort proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: comparative toxicity analysis of pcg 001-09
publisher Elsevier
series Clinical and Translational Radiation Oncology
issn 2405-6308
publishDate 2019-11-01
description Background and purpose: Patient-level benefits of proton beam therapy (PBT) relative to photon therapy for prostate cancer (PC) continue to be the focus of debate. Although trials comparing the two modalities are underway, most are being conducted using “conventional” PBT (passive scattering/uniform scanning [PS/US]) rather than pencil beam scanning (PBS). The dosimetric benefits of PBS are well-known, but comparative data are limited. This analysis compares PBS toxicity rates with those of PS/US in a prospective multicenter registry. Methods: We evaluated acute/late gastrointestinal (GI) and genitourinary (GU) toxicity rates for men with low-to-intermediate risk PC enrolled in PCG 001-09. Acute toxicities with the two techniques were compared using χ2 tests, and the cumulative incidence methods for late toxicity. Multivariable analyses (MVAs) for acute toxicity were performed using logistic regression, and cox proportional hazards models for late toxicity. Results: Patients were treated using PS/US (n = 1105) or PBS (n = 238). Acute grade ≥2 GI toxicity in PBS did not significantly differ from that with PS/US (2.9% and 2.1%, respectively; P = 0.47). Acute grade ≥2 GU toxicity was significantly higher with PBS (21.9% and 15.1%; P < 0.01). In MVA, PBS was significantly associated with increased acute grade ≥2 GU toxicity (RR = 1.57, p < 0.001). Late grade ≥2 GI and GU toxicities did not differ significantly between groups. Conclusions: This is the first multi-institutional comparative effectiveness evaluation of PBT techniques in PC. Differences in acute GU toxicity warrant further evaluation, and highlight the urgent need for prospective data using PBT. Keywords: Prostate cancer, Proton therapy, Pencil beam scanning, Passive scattering, uniform scanning, Comparative effectiveness, Toxicity
url http://www.sciencedirect.com/science/article/pii/S2405630819300941
work_keys_str_mv AT markvmishra protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
AT rahulkhairnar protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
AT sørenmbentzen protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
AT garylarson protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
AT henrytsai protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
AT christophersinesi protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
AT carlosvargas protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
AT georgelaramore protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
AT carlrossi protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
AT lanerosen protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
AT mingyaozhu protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
AT williamhartsell protonbeamtherapydeliveredusingpencilbeamscanningvspassivescatteringuniformscanningforlocalizedprostatecancercomparativetoxicityanalysisofpcg00109
_version_ 1721404586015588352